Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) major shareholder Robert Williams, Jr. sold 14,500,002 shares of Aveanna Healthcare stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total value of $166,750,023.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.
Aveanna Healthcare Stock Performance
AVAH stock opened at $13.62 on Thursday. The company has a debt-to-equity ratio of 4.47, a quick ratio of 1.16 and a current ratio of 1.16. The stock has a market capitalization of $2.97 billion, a price-to-earnings ratio of 11.07, a PEG ratio of 0.85 and a beta of 1.90. Aveanna Healthcare Holdings Inc. has a 1 year low of $5.93 and a 1 year high of $13.98. The stock’s fifty day moving average is $9.95 and its two-hundred day moving average is $8.03.
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last released its quarterly earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The business had revenue of $670.48 million during the quarter, compared to analyst estimates of $638.61 million. On average, research analysts predict that Aveanna Healthcare Holdings Inc. will post 0.75 EPS for the current year.
Institutional Inflows and Outflows
Analyst Ratings Changes
Several research firms have commented on AVAH. UBS Group upped their target price on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the stock a “neutral” rating in a research report on Friday, August 14th. Truist Financial boosted their price objective on Aveanna Healthcare from $11.00 to $15.00 and gave the stock a “hold” rating in a research report on Monday. Raymond James Financial boosted their price objective on Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a research report on Friday, August 14th. BMO Capital Markets increased their price objective on Aveanna Healthcare from $10.00 to $14.00 and gave the stock an “outperform” rating in a report on Friday, August 14th. Finally, Barclays raised their target price on Aveanna Healthcare from $9.00 to $9.50 and gave the company an “overweight” rating in a research report on Thursday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $12.89.
Read Our Latest Stock Report on AVAH
About Aveanna Healthcare
Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.
In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.
Further Reading
- Five stocks we like better than Aveanna Healthcare
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
